Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis
暂无分享,去创建一个
Jacob I. Ayers | D. Borchelt | P. Hart | Keith W Crosby | J. Ayers | Hilda H. Brown | Anthony M. Crown | Brittany L. Roberts | Anthony M Crown | Keith W. Crosby | B. L. Roberts
[1] D. Pizzo,et al. Misfolded SOD1 is not a primary component of sporadic ALS , 2017, Acta Neuropathologica.
[2] Jacob I. Ayers,et al. Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models , 2017, Journal of neurochemistry.
[3] Bryan F. Shaw,et al. Stochastic Formation of Fibrillar and Amorphous Superoxide Dismutase Oligomers Linked to Amyotrophic Lateral Sclerosis. , 2016, ACS chemical neuroscience.
[4] T. Saio,et al. Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis* , 2015, The Journal of Biological Chemistry.
[5] J. Valentine,et al. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation* , 2015, The Journal of Biological Chemistry.
[6] Eamonn F. Healy. A model for non-obligate oligomer formation in protein aggregration. , 2015, Biochemical and biophysical research communications.
[7] Bryan F. Shaw,et al. Arresting amyloid with coulomb's law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation. , 2015, Biophysical journal.
[8] John A Tainer,et al. Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes , 2014, Proceedings of the National Academy of Sciences.
[9] J. Attems,et al. Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot , 2014, Acta neuropathologica communications.
[10] D. Borchelt,et al. Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases , 2014, Acta neuropathologica communications.
[11] C. Angelini,et al. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants , 2014, Neurobiology of Aging.
[12] A. Hill,et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.
[13] H. Kusaka,et al. An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation , 2014, Neuropathology (Kyoto. 1993).
[14] Jacob I. Ayers,et al. Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease , 2014, Journal of neurochemistry.
[15] E. L. Guenther,et al. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS , 2013, Proceedings of the National Academy of Sciences.
[16] L. Piedrafita,et al. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. , 2013, Journal of neuropathology and experimental neurology.
[17] D. Borchelt,et al. Role of Disulfide Cross-Linking of Mutant SOD1 in the Formation of Inclusion-Body-Like Structures , 2012, PloS one.
[18] A. Nakamura,et al. Distinctive clinicopathological features of 2 large families with amyotrophic lateral sclerosis having L106V mutation in SOD1 gene , 2012, Journal of the Neurological Sciences.
[19] M. Gearing,et al. Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS , 2012, Proceedings of the National Academy of Sciences.
[20] D. Borchelt,et al. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states , 2011, Molecular Neurodegeneration.
[21] S. Dunn,et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS , 2011, Proceedings of the National Academy of Sciences.
[22] D. Borchelt,et al. Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice* , 2010, The Journal of Biological Chemistry.
[23] J. Rumfeldt,et al. Nonamyloid Aggregates Arising from Mature Copper/Zinc Superoxide Dismutases Resemble Those Observed in Amyotrophic Lateral Sclerosis* , 2010, The Journal of Biological Chemistry.
[24] Jeffery N Agar,et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS , 2010, Nature Neuroscience.
[25] Johan Jacobsson,et al. Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients , 2010, PloS one.
[26] D. Borchelt,et al. Copper–Zinc Superoxide Dismutase, Its Copper Chaperone, and Familial Amyotrophic Lateral Sclerosis , 2010 .
[27] A. Bertolotti,et al. Exposure of Hydrophobic Surfaces Initiates Aggregation of Diverse ALS-Causing Superoxide Dismutase-1 Mutants , 2010, Journal of molecular biology.
[28] N. Nukina,et al. Mutation-dependent Polymorphism of Cu,Zn-Superoxide Dismutase Aggregates in the Familial Form of Amyotrophic Lateral Sclerosis* , 2010, The Journal of Biological Chemistry.
[29] P. Andersen,et al. SOD1 Mutations Targeting Surface Hydrogen Bonds Promote Amyotrophic Lateral Sclerosis without Reducing Apo-state Stability* , 2010, The Journal of Biological Chemistry.
[30] S. Croul,et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form , 2010, Acta Neuropathologica.
[31] H. Neumann,et al. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1 , 2009, Neurobiology of Disease.
[32] D. Borchelt,et al. Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis , 2009, Experimental biology and medicine.
[33] D. Borchelt,et al. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.
[34] D. Borchelt,et al. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS , 2009, Proceedings of the National Academy of Sciences.
[35] J. Yates,et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS , 2009, Proceedings of the National Academy of Sciences.
[36] Julian P. Whitelegge,et al. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase , 2008, Proceedings of the National Academy of Sciences.
[37] I. Tooyama,et al. The endoplasmic reticulum‐Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] D. Borchelt,et al. A Limited Role for Disulfide Cross-linking in the Aggregation of Mutant SOD1 Linked to Familial Amyotrophic Lateral Sclerosis* , 2008, Journal of Biological Chemistry.
[39] K. Oyanagi,et al. Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: A clinical and neuropathological study , 2008, Journal of the Neurological Sciences.
[40] P. Andersen,et al. Inclusions of amyotrophic lateral sclerosis–linked superoxide dismutase in ventral horns, liver, and kidney , 2008, Annals of neurology.
[41] I. Bertini,et al. SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization , 2008, PloS one.
[42] R. Strange,et al. Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu–Zn superoxide dismutase , 2007, Proceedings of the National Academy of Sciences.
[43] R. Kopito,et al. Impaired post‐translational folding of familial ALS‐linked Cu, Zn superoxide dismutase mutants , 2007, The EMBO journal.
[44] P. Andersen,et al. Motor Neuron Disease in Mice Expressing the Wild Type-Like D90A Mutant Superoxide Dismutase-1 , 2006, Journal of neuropathology and experimental neurology.
[45] X. Yao,et al. SUMO-1 modification increases human SOD1 stability and aggregation , 2006, Neuroscience Research.
[46] Fujian Zhang,et al. Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. , 2006, Biochimica et biophysica acta.
[47] P. Andersen,et al. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. , 2006, Brain : a journal of neurology.
[48] D. Borchelt,et al. Mapping superoxide dismutase 1 domains of non‐native interaction: roles of intra‐ and intermolecular disulfide bonding in aggregation , 2006, Journal of neurochemistry.
[49] R. Morimoto,et al. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates , 2005, The Journal of cell biology.
[50] D. Borchelt,et al. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. , 2005, Human molecular genetics.
[51] Bryan F. Shaw,et al. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[52] T. O’Halloran,et al. Amyotrophic Lateral Sclerosis Mutations Have the Greatest Destabilizing Effect on the Apo- and Reduced Form of SOD1, Leading to Unfolding and Oxidative Aggregation* , 2005, Journal of Biological Chemistry.
[53] A. Hill,et al. Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis , 2005, The Journal of Neuroscience.
[54] Borries Demeler,et al. Dissociation of Human Copper-Zinc Superoxide Dismutase Dimers Using Chaotrope and Reductant , 2004, Journal of Biological Chemistry.
[55] I. Bertini,et al. The Unusually Stable Quaternary Structure of Human Cu,Zn-Superoxide Dismutase 1 Is Controlled by Both Metal Occupancy and Disulfide Status* , 2004, Journal of Biological Chemistry.
[56] A. Holmgren,et al. Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Yazawa,et al. Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions , 2004, Journal of the Neurological Sciences.
[58] S. Tsuji,et al. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation , 2004, Acta Neuropathologica.
[59] Timothy J Mitchison,et al. A Novel Action of Histone Deacetylase Inhibitors in a Protein Aggresome Disease Model , 2004, Current Biology.
[60] D. Borchelt,et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. , 2003, Human molecular genetics.
[61] John A Tainer,et al. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. , 2003, Journal of molecular biology.
[62] Jennifer Stine Elam,et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS , 2003, Nature Structural Biology.
[63] A. Chakrabartty,et al. Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.
[64] Robert H. Brown,et al. Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis* 210 , 2002, The Journal of Biological Chemistry.
[65] D. Borchelt,et al. High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.
[66] S. Sakoda,et al. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation , 2001, Acta Neuropathologica.
[67] M. Nishibori,et al. Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and lewy body-like hyaline inclusions. , 2001, Archives of neurology.
[68] S. Minotti,et al. Mutant Cu/Zn-Superoxide Dismutase Proteins Have Altered Solubility and Interact with Heat Shock/Stress Proteins in Models of Amyotrophic Lateral Sclerosis* , 2001, The Journal of Biological Chemistry.
[69] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[70] S. Tsuji,et al. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. , 1999, Archives of neurology.
[71] D. Borchelt,et al. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. , 1999, Human molecular genetics.
[72] D. Eisenberg,et al. A structure-based mechanism for copper-zinc superoxide dismutase. , 1999, Biochemistry.
[73] S. Tsuji,et al. Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions , 1998, Neurology.
[74] Matteo Pellegrini,et al. Subunit asymmetry in the three‐dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis , 1998, Protein science : a publication of the Protein Society.
[75] J. Powell,et al. Familial amyotrophic lateral sclerosis , 1997, Neurology.
[76] W. Hung,et al. Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.
[77] D. Eisenberg,et al. Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. , 1996, Biochemistry.
[78] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[79] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[80] J. Valentine,et al. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[81] D. Borchelt,et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[82] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[83] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[84] J. Tainer,et al. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[85] S. Nagata,et al. pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.
[86] I. Fridovich,et al. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.
[87] P. Andersen,et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. , 2013, Human molecular genetics.
[88] Taewook Kang,et al. Lipid molecules induce the cytotoxic aggregation of Cu/Zn superoxide dismutase with structurally disordered regions. , 2011, Biochimica et biophysica acta.
[89] P. Andersen,et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. , 2004, Brain : a journal of neurology.
[90] N. Shibata,et al. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. , 1996, Developmental neuroscience.
[91] I. Fridovich,et al. Superoxide dismutases. , 1975, Annual review of biochemistry.